None
Quote | Innovative Properties Inc (OTCMKTS:INNPF)
Last: | $0.2081 |
---|---|
Change Percent: | -0.05% |
Open: | $0.2082 |
Close: | $0.2081 |
High: | $0.2082 |
Low: | $0.2081 |
Volume: | 20,000 |
Last Trade Date Time: | 04/16/2024 03:00:00 am |
News | Innovative Properties Inc (OTCMKTS:INNPF)
Innocan Pharma Initiates FDA Approval Process for Liposome Injection Therapy for Chronic Pain Canada NewsWire With its submission of a Pre-IND Meeting Request Letter, Innocan initiates the regulatory process with the U.S. Food and Drug Administration (FDA) for the approval of ...
Innocan Pharma Reports Full Year 2023 Results with Revenues up Nearly 6X to $13.7M Canada NewsWire HERZLIYA, Israel and CALGARY, Alberta , April 1, 2024 /CNW/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTC: INNPF) (the "Company" or "Innocan"), a ph...
Message Board Posts | Innovative Properties Inc (OTCMKTS:INNPF)
Subject | By | Source | When |
---|---|---|---|
CEO steals people ideas, wastes people time and | InvestorNews1 | investorshub | 04/01/2022 11:06:34 AM |
CEO is a con artist | InvestorNews1 | investorshub | 04/01/2022 11:05:13 AM |
CEO IRIS Is pumping the stock... DON'T WASTE | InvestorNews1 | investorshub | 04/01/2022 11:02:06 AM |
News, Short Squeeze, Breakout and More Instantly...
Innovative Properties Inc Company Name:
INNPF Stock Symbol:
OTCMKTS Market:
Innovative Properties Inc Website:
Innocan Pharma Corporation (CSE:INNO) (FSE: IP4) (OTCQB:INNPF) announced on Monday that it has submitted its letter of application for a Pre-IND me...
Innocan Pharma Initiates FDA Approval Process for Liposome Injection Therapy for Chronic Pain Canada NewsWire With its submission of a Pre-IND Meeting Request Letter, Innocan initiates the regulatory process with the U.S. Food and Drug Administration (FDA) for the approval of ...
Innocan Pharma Reports Full Year 2023 Results with Revenues up Nearly 6X to $13.7M Canada NewsWire HERZLIYA, Israel and CALGARY, Alberta , April 1, 2024 /CNW/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTC: INNPF) (the "Company" or "Innocan"), a ph...